ANDAORALTABLET
Approved
Apr 2022
Lifecycle
Post-LOE
Competitive Pressure
30/100
Mechanism of Action
5-HT 1B/1D receptors. The therapeutic activity of frovatriptan succinate is thought to be due to the agonist effects at the 5-HT 1B/1D receptors on intracranial blood vessels (including the arterio-venous anastomoses) and sensory nerves of the trigeminal system which result in cranial vessel…